NCT06967922

Brief Summary

The main objective of this study, conducted in a population with acute insomnia disorder (stress), was to investigate the efficacy of Analytic-Integrative Cognitive Behavioural Therapy in the treatment of acute insomnia disorder (stress).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 5, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

May 23, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

May 5, 2025

Last Update Submit

May 19, 2025

Conditions

Keywords

Acute insomnia disorderAnalytic-Integrative Cognitive Behavioural Therapystress

Outcome Measures

Primary Outcomes (1)

  • The change of Pittsburgh Sleep Quality Index (PSQI) total scores from baseline to 6 weeks.

    The PSQI consists of 7 factors ranging from 0 to 3 points, and the total score ranges from 0 to 21 with higher scores indicating poorer quality.

    Baseline, 6 weeks

Secondary Outcomes (4)

  • The change of Beck Depression Inventory (BDI) total scores from baseline to 6 weeks, 3 months, 6 months, and 12 months.

    Baseline, 6 weeks, 3 months, 6 months, and 12 months

  • The change of Beck Anxiety Inventory (BAI) total scores from baseline to 6 weeks, 3 months, 6 months, and 12 months.

    Baseline, 6 weeks, 3 months, 6 months, and 12 months

  • The change of Snaith-Hamilton Pleasure Scale (SHAPS) total scores from baseline to 6 weeks, 3 months, 6 months, and 12 months.

    Baseline, 6 weeks, 3 months, 6 months, and 12 months

  • The change of Insomnia severity index (ISI) total scores from baseline to 6 weeks, 3 months, 6 months, and 12 months.

    Baseline, 6 weeks, 3 months, 6 months, and 12 months

Study Arms (2)

Acceptance analysis - integrated cognitive behavioral therapy

EXPERIMENTAL
Behavioral: Analytic-Integrative Cognitive Behavioural Therapy

Receive sleep hygiene education

ACTIVE COMPARATOR
Other: Sleep hygiene education

Interventions

Analytic-Integrative Cognitive-Behavioural Approach: Initial Interview for Information Gathering: comprehensive collection of patient information; Assessment: collection of multidimensional factors; Diagnosis: insomnia and co-morbidities; Analytic-Integrative Analysis for Treatment Decision Making.

Acceptance analysis - integrated cognitive behavioral therapy

Participants will receive Sleep Hygiene Education (SHE) alone for 6 weeks. SHE involves education on maintaining consistent sleep schedules, creating a sleep-conducive environment, reducing stimulant use (e.g., caffeine, alcohol), and promoting healthy daily routines to improve sleep quality.

Receive sleep hygiene education

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • meeting the DSM-5 diagnostic criteria for insomnia disorder;
  • a total score of \>5 on the Pittsburgh Sleep Quality Index (PSQI);
  • age ≥18 years old, with junior high school education or above;
  • voluntarily participating in this study and signing an informed consent form;
  • the diagnostic criteria for acute insomnia disorder (duration of the disease less than 3 months).

You may not qualify if:

  • people with comorbid serious physical or severe mental illnesses, suicide risk;
  • clinically diagnosed or suspected sleep breathing disorder, restless legs syndrome and sleep-wake rhythm disorder, shift workers;
  • pregnant and breastfeeding women;
  • people who are currently undergoing any psychological treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xuanwu Hospital, Capital Medical University

Beijing, 100053, China

RECRUITING

Central Study Contacts

Hongxing Wang, MD & PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 5, 2025

First Posted

May 13, 2025

Study Start

November 1, 2024

Primary Completion

October 1, 2025

Study Completion

November 1, 2025

Last Updated

May 23, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations